News: Optiscan raising funds as medical imaging launch beckons

Optiscan (ASX:OIL) has raised $690,000 through its fully underwritten 1 for 15 entitlements issue priced at $0.05 as it nears the launch of the second generation medical imaging systems.

This follows the company securing a short term $500,000 debt facility.

The second generation CellLIVE animal imaging system is scheduled for release in September 2015 at the World Molecular Imaging Conference in Hawaii.

Optiscan is also continuing its discussions with Carl Zeiss over the final stages of the project to deliver its neurosurgery confocal imaging system.